Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study
We review your health history, goals, and any previous weight loss attempts and determine whether GLP-1 therapy is the right fit for you
Hormones, metabolism, insulin resistance, genetics, and lifestyle factors can all influence your ability to lose weight and keep it off
Pure Medical Spa offers virtual medical weight loss Illinois programs
Severe allergic reactions require immediate discontinuation and emergency treatment
Limitations Reflect Gaps in Ophthalmologic Monitoring The researchers acknowledged several study limitations, including substantial variability in assessment methods, the absence of a specific ICD-10 code for NAION, and the exclusion of participants with advanced diabetic eye disease, and stressed the need for additional research regarding the relationship between semaglutide and NAION The authors concluded, Treatment with semaglutide in adults was not associated with an increased risk of eye disorders or DR in this study, and future studies are unlikely to change these results